VIVANI MEDICAL INC (VANI) Fundamental Analysis & Valuation
NASDAQ:VANI • US92854B1098
Current stock price
1.15 USD
-0.03 (-2.54%)
Last:
This VANI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. VANI Profitability Analysis
1.1 Basic Checks
- In the past year VANI has reported negative net income.
- In the past year VANI has reported a negative cash flow from operations.
- In the past 5 years VANI always reported negative net income.
- In the past 5 years VANI always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -103.91%, VANI is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
- The Return On Equity of VANI (-1988.24%) is worse than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.91% | ||
| ROE | -1988.24% | ||
| ROIC | N/A |
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. VANI Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, VANI has more shares outstanding
- Compared to 5 years ago, VANI has more shares outstanding
- VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- VANI has an Altman-Z score of -9.22. This is a bad value and indicates that VANI is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -9.22, VANI is not doing good in the industry: 78.84% of the companies in the same industry are doing better.
- There is no outstanding debt for VANI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.22 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.61 indicates that VANI may have some problems paying its short term obligations.
- With a Current ratio value of 0.61, VANI is not doing good in the industry: 91.01% of the companies in the same industry are doing better.
- A Quick Ratio of 0.61 indicates that VANI may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.61, VANI is doing worse than 89.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.61 |
3. VANI Growth Analysis
3.1 Past
- VANI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, VANI will show a very negative growth in Earnings Per Share. The EPS will decrease by -19.85% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y4.95%
EPS Next 2Y9.02%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. VANI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for VANI. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VANI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- VANI's earnings are expected to decrease with -3.62% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.02%
EPS Next 3Y-3.62%
5. VANI Dividend Analysis
5.1 Amount
- No dividends for VANI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VANI Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:VANI (3/24/2026, 2:26:49 PM)
1.15
-0.03 (-2.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)03-26 2026-03-26
Inst Owners6.72%
Inst Owner Change31.96%
Ins Owners44.11%
Ins Owner Change0.21%
Market Cap93.39M
Revenue(TTM)N/A
Net Income(TTM)-26.03M
Analysts82.22
Price Target5.1 (343.48%)
Short Float %0.56%
Short Ratio0.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.84%
Min EPS beat(2)-17.65%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-4.11%
Min EPS beat(4)-17.65%
Max EPS beat(4)1.96%
EPS beat(8)6
Avg EPS beat(8)3.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 71.35 | ||
| P/tB | 71.35 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.91% | ||
| ROE | -1988.24% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 300.25% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | -9.22 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)158.98%
Cap/Depr(5y)139.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y4.95%
EPS Next 2Y9.02%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.57%
EBIT Next 3Y-15.98%
EBIT Next 5Y-39.03%
FCF growth 1Y3.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3YN/A
OCF growth 5YN/A
VIVANI MEDICAL INC / VANI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for VIVANI MEDICAL INC?
ChartMill assigns a fundamental rating of 1 / 10 to VANI.
What is the valuation status for VANI stock?
ChartMill assigns a valuation rating of 0 / 10 to VIVANI MEDICAL INC (VANI). This can be considered as Overvalued.
Can you provide the profitability details for VIVANI MEDICAL INC?
VIVANI MEDICAL INC (VANI) has a profitability rating of 0 / 10.
Can you provide the financial health for VANI stock?
The financial health rating of VIVANI MEDICAL INC (VANI) is 4 / 10.